Definitive Contract HHSN261201400033C
Award Date 9/19/14
Potential Completion Date 7/17/15
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Natick, MA 01760, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) and National Institute on Drug Abuse to Xtal Biostructures, Inc., a biotechnology company that specializes in protein crystallization, x-ray crystallography, and biochemical product services. The $12,500.00 firm fixed price purchase order contract is for Xtal Biostructures to provide protein crystallization, x-ray crystallography, testing, and protein generation services to...
- This federal contract award to Xtal Biostructures Inc., a small business subchapter S corporation, was issued by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). The $97,000 firm-fixed-price purchase order is for protein crystallization and x-ray crystallography services on the Large Tumor Suppressor Kinase 1 (LATS1) protein to support NCATS' preclinical research initiatives. The original sources sought notice was issued as a...
- This federal contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to The New York Structural Biology Center, Inc., a non-profit organization, to provide services generating high resolution X-ray crystal structures of the extracellular domains of chimeric antigen receptor (CAR) proteins and other immunologically relevant surface receptors and co-receptors, as well as their interactions with tumor antigens. The contract is...
- This federal contract award, valued at $469,429.60, was made by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services, to Astrix Technology LLC (doing business as Astrix Technology Group). The contract provides support services, including biologists, to the Laboratory of Genome Integrity at the NCI's Center for Cancer Research. This is a Blanket Purchase Agreement (BPA) call under Astrix's existing $19 million...
- This is a federal contract award to Biotex, Inc., a for-profit organization and manufacturer of goods, by the National Cancer Institute (NCI), a civilian agency. The contract is for the "Development of Alternative Affinity Capture Reagents for Cancer Proteomics Research" under the Small Business Innovation Research (SBIR) Phase II program, with a total ceiling value of $749,995.92. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an ultimate...
- This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute (NCI), a component of the National Institutes of Health, to 10X Genomics, Inc. for the procurement of biological and reagent materials. The award, valued at $24,178.54 with a firm fixed-price structure, was executed on September 14, 2022, with an ultimate completion date of November 30, 2022. The contract was awarded without set-aside designation and is to be performed at 10X...
- The National Cancer Institute awarded a $23,107.44 firm fixed-price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc. for biological kits on June 30, 2022, with an ultimate completion date of July 30, 2022. The contract, which carries no set-aside designation, is for work to be performed at the awardee's location in Pleasanton, California. This award represents a task order or call against an existing BPA vehicle, a procurement mechanism that allows federal agencies to place orders...
- This federal contract award is for $189,536 and was issued by the National Cancer Institute, a civilian agency under the Department of Health and Human Services. The contract was awarded to Astrix Technology LLC, doing business as Astrix Technology Group, a for-profit limited liability company that specializes in providing expert scientific, technical, and administrative services to support federal agencies' research initiatives. The contract is a task order under a $19 million blanket...
- This is a federal contract award from the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to Astrix Technology LLC, doing business as Astrix Technology Group. The $97,175.20 firm-fixed-price contract was awarded on November 1, 2021 and has an ultimate completion date of October 30, 2022. The contract is for Astrix Technology to provide a biologist familiar with the National Cancer Institute's research to independently conduct experiments, present...
- This contract was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for $37,449.20 and was awarded to Astrix Technology LLC, doing business as Astrix Technology Group, a provider of scientific, technical, and administrative support services to federal agencies. The contract is a Blanket Purchase Agreement (BPA) call order under Astrix's existing $19 million BPA...
This federal contract award, valued at $148,110.00, was issued by the National Cancer Institute (an agency of the National Institutes of Health) to Xtal Biostructures Inc., a biotechnology company that specializes in protein crystallization, x-ray crystallography, and biochemical product generation. The contract is for the "GENERATION OF SITE SPECIFIC PHOSPHO-THREONINE PROTEIN STANDARDS FOR USE IN CANCER ASSAYS". This work supports the National Cancer Institute's research efforts. Xtal Biostructures has previously been awarded other federal contracts and subcontracts from agencies such as the National Institutes of Health and National Institute on Drug Abuse for similar services. The contract does not have a set-aside designation.
Generated 11/24/24, 9:36 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
PHS 2014-1 Amendment 3 | PHS-2014-1 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 8/14/13, 6:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 6/16/15 | |
| 1 | Other Administrative Action | $0 | 11/19/14 | |
| Not listed | Not listed | $148.1k | 9/18/14 |